Skip to content
Oxcia
Menu
Close
About us
Open menu
About us
Management
Board
Scientific Advisory Board
Collaborators
Partnerships
History
Careers
Scientific Platform
Open menu
Scientific Platform
Glossary
Pipeline
Open menu
Pipeline
OXC-101
OXC-201
Investors
Open menu
Investors
Governance
Ownership structure
Financial reports
Presentations
Upcoming events
Investor contact
Investerare
Open menu
Investerare
Bolagsstyrning
Bolagsstämma
Ägarstruktur
Finansiella rapporter
Pressmeddelanden
Presentationer
Kalender
Investerarkontakt
News and Press
Contact
Search
Home
›
New tablet formulation of karonudib is introduced in the clinical trials
New tablet formulation of karonudib is introduced in the clinical trials
November 18, 2020
Latest news
New publications in peer-reviewed scientific journals support the potential for OXC-101 as a novel anti-cancer therapy
June 11, 2024
Kommuniké från årsstämma i Oxcia AB den 21 maj 2024
May 22, 2024
Patentgodkännande har nu även säkrats i USA, den största IPF-marknaden
May 17, 2024
Read more news
Search
More results
Generic filters
Search!